Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « AbsEn.i » - entrée « therapy »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
theraprutic < therapy < there  Facettes :

List of bibliographic references indexed by therapy

Number of relevant bibliographic references: 1438.
[0-50] [0 - 20][0 - 50][50-70]
Ident.Authors (with country if any)Title
000004 (2020) Mike Becker [Suisse][Polymyalgia rheumatica and Giant Cell Arteritis - Update on Diagnosis and Therapy].
000006 (2020) Anna Jakubczyc ; Claus Neurohr[Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
000008 (2020) J. Prinz [Allemagne] ; Y. D'Hargues [Allemagne] ; P. Gödel [Allemagne] ; A. Shimabukuro-Vornhagen [Allemagne] ; M. Kochanek [Allemagne] ; B. Böll [Allemagne][CARs, CRS and neurotoxicity: severe complications after administration of immunotherapy : Essentials for intensivists].
000010 (2020) Aline Pfefferle [Australie] ; Nicholas D. Huntington [Australie]You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
000020 (2020) Jared Radbel [États-Unis] ; Navaneeth Narayanan [États-Unis] ; Pinki J. Bhatt [États-Unis]Use of tocilizumab for COVID-19 infection-induced cytokine release syndrome: A cautionary case report.
000029 (2020) Sara Benchérifa ; Bouchra Amine ; Imane El Binoune ; Samira Rostom ; Rachid BahiriTwo cases of perforated corneal ulcers complicating rheumatoid arthritis treated successfully by biological therapy
000032 (2020) Marc Feldmann [Royaume-Uni] ; Ravinder N. Maini [Royaume-Uni] ; James N. Woody [États-Unis] ; Stephen T. Holgate [Royaume-Uni] ; Gregory Winter [Royaume-Uni] ; Matthew Rowland [Royaume-Uni] ; Duncan Richards [Royaume-Uni] ; Tracy Hussell [Royaume-Uni]Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
000035 (2020) Limin Li [République populaire de Chine] ; Jie Liu [République populaire de Chine] ; Mengyuan Xu [République populaire de Chine] ; Hongjuan Yu [République populaire de Chine] ; Chengfang Lv [République populaire de Chine] ; Fenglin Cao [République populaire de Chine] ; Zhenkun Wang [République populaire de Chine] ; Yueyue Fu [République populaire de Chine] ; Mingwen Zhang [République populaire de Chine] ; Hongbin Meng [République populaire de Chine] ; Xiaoqian Zhang [République populaire de Chine] ; Liqing Kang [République populaire de Chine] ; Zhuo Zhang [République populaire de Chine] ; Jinmei Li [République populaire de Chine] ; Jiawei Feng [République populaire de Chine] ; Xin Lian [République populaire de Chine] ; Lei Yu [République populaire de Chine] ; Jin Zhou [République populaire de Chine]Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients
000036 (2020) B P Hibler [États-Unis] ; A. Markova [États-Unis]Treatment of severe cutaneous adverse reaction with tocilizumab.
000042 (2020) Prakhar Vijayvargiya [États-Unis] ; Zerelda Esquer Garrigos [États-Unis] ; Natalia E. Castillo Almeida [États-Unis] ; Pooja R. Gurram [États-Unis] ; Ryan W. Stevens [États-Unis] ; Raymund R. Razonable [États-Unis]Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)
000044 (2020) Ernest H. Choy [Royaume-Uni] ; Fabrizio De Benedetti [Italie] ; Tsutomu Takeuchi [Japon] ; Misato Hashizume [Japon] ; Markus R. John [Suisse] ; Tadamitsu Kishimoto [Japon]Translating IL-6 biology into effective treatments
000046 (2020) Gabriela Sanchez-Petitto [États-Unis] ; Noa G. Holtzman [États-Unis] ; Ali Bukhari [États-Unis] ; Matthew Brown [États-Unis] ; Megan K. Morales [États-Unis] ; Madhurima Koka [États-Unis] ; Jean A. Yared [États-Unis] ; Saurabh Dahiya [États-Unis] ; Aaron P. Rapoport [États-Unis] ; Nancy M. Hardy [États-Unis]Toxoplasma-induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantation.
000050 (2020) Daichi Fukaya [Japon] ; Tsutomu Inoue [Japon] ; Yuta Kogure [Japon] ; Hiroshi Kajiyama [Japon] ; Keisuke Ishizawa [Japon] ; Takeru Seto [Japon] ; Hajime Hasegawa [Japon] ; Toshihide Mimura [Japon] ; Hirokazu Okada [Japon]Tocilizumab-induced immunocomplex glomerulonephritis: a report of two cases.
000055 (2020) Pan Luo [République populaire de Chine] ; Yi Liu [République populaire de Chine] ; Lin Qiu [République populaire de Chine] ; Xiulan Liu [République populaire de Chine] ; Dong Liu [République populaire de Chine] ; Juan Li [République populaire de Chine]Tocilizumab treatment in COVID-19: A single center experience.
000065 (2020) Ian Pirker [Suisse] ; Andrea Rubbert-Roth [Suisse] ; Johannes Von Kempis [Suisse] ; Martin Fehr [Suisse] ; Thomas Neumann [Suisse]Tocilizumab in a patient with newly diagnosed rheumatoid arthritis secondary to checkpoint inhibitor therapy.
000079 (2020) Caterina Vacchi [Italie] ; Marco Sebastiani [Italie] ; Giulia Cassone [Italie] ; Stefania Cerri [Italie] ; Giovanni Della Casa [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
000087 (2020) Wanhai Ke ; Li Zhang ; Yan DaiThe role of IL‐6 in immunotherapy of non‐small cell lung cancer (NSCLC) with immune‐related adverse events (irAEs)
000098 (2020) Seda Colak [Turquie] ; Emre Tekgoz [Turquie] ; Muhammet Cinar [Turquie] ; Sedat Yilmaz [Turquie]The assessment of tocilizumab therapy on recurrent attacks of patients with familial Mediterranean fever: A retrospective study of 15 patients.
000100 (2020) Jianan Xu [République populaire de Chine] ; Huijing Ye [République populaire de Chine] ; Guo Chen [République populaire de Chine] ; Jingqiao Chen [République populaire de Chine] ; Rongxin Chen [République populaire de Chine] ; Huasheng Yang [République populaire de Chine]The Therapeutic Effect of Combination of Orbital Decompression Surgery and Methylprednisolone Pulse Therapy on Patients with Bilateral Dysthyroid Optic Neuropathy
000101 (2020) Mohammed Shah ; Derek M. Yellon ; Sean M. DavidsonThe Role of Extracellular DNA and Histones in Ischaemia-Reperfusion Injury of the Myocardium
000122 (2020) Timothy M. Smith ; Anuj Tharakan ; Rebecca K. MartinTargeting ADAM10 in Cancer and Autoimmunity
000123 (2020) Huizhi Wang ; Zihang Chen ; Shaobo Wang ; Xiao Gao ; Mingyu Qian ; Wei Qiu ; Zongpu Zhang ; Shouji Zhang ; Yanhua Qi ; Xiaopeng Sun ; Hao Xue ; Xing Guo ; Rongrong Zhao ; Gang LiTGFβ1‐induced beta‐site APP‐cleaving enzyme 2 upregulation promotes tumorigenesis through the NF‐κB signalling pathway in human gliomas
000126 (2020) E C Schwaneck [Allemagne] ; R. Renner [Allemagne] ; L. Junker [Allemagne] ; H-P Tony [Allemagne] ; S. Kleinert [Allemagne] ; M. Gernert [Allemagne] ; M. Schmalzing [Allemagne] ; O. Gadeholt [Allemagne]T cells, natural killer cells, and γδT cells in a large patient cohort with rheumatoid arthritis: influence of age and anti-rheumatic therapy.
000128 (2020) Sophie Testa [Italie] ; Oriana Paoletti [Italie] ; Matteo Giorgi-Pierfranceschi [Italie] ; Angelo Pan [Italie]Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
000138 (2020) Hao Zhang ; Yongxian HuSuccessful treatment of T315I BCR-ABL mutated lymphoid blast phase chronic myeloid leukemia with chimeric antigen receptor T cell therapy followed by dasatinib
000139 (2020) Chayma Ladhari [France] ; Pierre Le Blay [France] ; Thierry Vincent [France] ; Ahmed Larbi [France] ; Emma Rubenstein [France] ; Rosanna Ferreira Lopez [France] ; Christian Jorgensen [France] ; Yves-Marie Pers [France]Successful long-term remission through tapering tocilizumab infusions: a single-center prospective study
000141 (2020) Adam Amlani [Canada] ; Claire Barber [Canada] ; Aurore Fifi-Mah [Canada] ; Jose Monzon [Canada]Successful Treatment of Cytokine Release Syndrome with IL-6 Blockade in a Patient Transitioning from Immune-Checkpoint to MEK/BRAF Inhibition: A Case Report and Review of Literature.
000151 (2020) Joanna Wai Yee Leong [Singapour] ; Peter P. Cheung [Singapour] ; Sajeewani Dissanayake [Singapour] ; Warren Weng Seng Fong [Singapour] ; Keng Hong Leong [Singapour] ; Ying Ying Leung [Singapour] ; Anita Yee Nah Lim [Singapour] ; Nai Lee Lui [Singapour] ; Mona Manghani [Singapour] ; Amelia Santosa [Singapour] ; Melonie Kannamma Sriranganathan [Singapour] ; Ernest Suresh [Singapour] ; Teck Choon Tan [Singapour] ; Gim Gee Teng [Singapour] ; Manjari Lahiri [Singapour]Singapore Chapter of Rheumatologists updated consensus statement on the eligibility for government subsidization of biologic and targeted-synthetic therapy for the treatment of rheumatoid arthritis.
000155 (2020) Meng Xu ; Congcong Liu ; Lishuang Guo ; Sirui YangSevere sepsis caused by serious gastrointestinal infection in sJIA patients treated with IL-6 receptor antagonist: a case report
000157 (2020) Jingsheng Hua [République populaire de Chine] ; Weiqing Qian [République populaire de Chine] ; Xiaoxia Wu [République populaire de Chine] ; Lili Zhou [République populaire de Chine] ; Lei Yu [République populaire de Chine] ; Suning Chen [République populaire de Chine] ; Jian Zhang [République populaire de Chine] ; Huiying Qiu [République populaire de Chine]Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature
000167 (2020) Peter A. Riedell ; Michael R. BishopSafety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas
000170 (2020) Renba Liang ; Xishan Chen ; Li Chen ; Fangzhu Wan ; Kaihua Chen ; Yongchu Sun ; Xiaodong ZhuSTAT3 signaling in ovarian cancer: a potential therapeutic target
000178 (2020) Adelaide Sofia Batalha Figueiredo [Portugal] ; Ana Luísa Oliveira [Portugal] ; Ant Nio Caetano [Portugal] ; Maria Francisca Moraes-Fontes [Portugal]SAPHO: has the time come for tailored therapy?
000179 (2020) Carolina Caro-Vegas [États-Unis] ; Subhashini Sellers [États-Unis] ; Kurtis M. Host [États-Unis] ; Jedediah Seltzer [États-Unis] ; Justin Landis [États-Unis] ; William A. Fischer [États-Unis] ; Blossom Damania [États-Unis] ; Dirk P. Dittmer [États-Unis]Runaway Kaposi Sarcoma-associated herpesvirus replication correlates with systemic IL-10 levels.
000187 (2020) Durga Prasanna Misra [Inde] ; Vikas Agarwal [Inde] ; Armen Yuri Gasparyan ; Olena Zimba [Ukraine]Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
000193 (2020) Ka-Tim Choy [République populaire de Chine] ; Alvina Yin-Lam Wong [République populaire de Chine] ; Prathanporn Kaewpreedee [République populaire de Chine] ; Sin Fun Sia [République populaire de Chine] ; Dongdong Chen [République populaire de Chine] ; Kenrie Pui Yan Hui [République populaire de Chine] ; Daniel Ka Wing Chu [République populaire de Chine] ; Michael Chi Wai Chan [République populaire de Chine] ; Peter Pak-Hang Cheung [République populaire de Chine] ; Xuhui Huang [République populaire de Chine] ; Malik Peiris [République populaire de Chine] ; Hui-Ling Yen [République populaire de Chine]Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
000197 (2020) Angela Ceribelli [Italie] ; Francesca Motta [Italie] ; Maria De Santis [Italie] ; Aftab A. Ansari [États-Unis] ; William M. Ridgway [États-Unis] ; M. Eric Gershwin [États-Unis] ; Carlo Selmi [Italie]Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
000201 (2020) Naomi Serling-Boyd [États-Unis] ; John H. StoneRecent advances in the diagnosis and management of giant cell arteritis.
000202 (2020) Giorgia Bucciol [Belgique] ; Isabelle Meyts [Belgique]Recent advances in primary immunodeficiency: from molecular diagnosis to treatment
000204 (2020) Jennie H. Best [États-Unis] ; Steven C. Vlad [États-Unis] ; Lenore Tominna [États-Unis] ; Ibrahim Abbass [États-Unis]Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic.
000210 (2020) Thomas Koudstaal ; Karin A. Boomars ; Mirjam KoolPulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective
000214 (2020) Alyson W. Wong [Canada] ; Christopher J. Ryerson [Canada] ; Sabina A. Guler [Suisse]Progression of fibrosing interstitial lung disease
000224 (2020) Jie Ma [République populaire de Chine] ; Peng Xia [République populaire de Chine] ; Yangzhong Zhou [République populaire de Chine] ; Zhengyin Liu [République populaire de Chine] ; Xiang Zhou [République populaire de Chine] ; Jinglan Wang [République populaire de Chine] ; Taisheng Li [République populaire de Chine] ; Xiaowei Yan [République populaire de Chine] ; Limeng Chen [République populaire de Chine] ; Shuyang Zhang [République populaire de Chine] ; Yan Qin [République populaire de Chine] ; Xuemei Li [République populaire de Chine]Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19
000227 (2020) Lauren E. Lee [États-Unis] ; Bradley W. Beeler [États-Unis] ; Brendan C. Graham [États-Unis] ; Andrew P. Cap [États-Unis] ; Nay Win [Royaume-Uni] ; Frederick Chen [Royaume-Uni]Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab.
000233 (2020) Giulia Cassone [Italie] ; Marco Sebastiani [Italie] ; Caterina Vacchi [Italie] ; Stefania Cerri [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming?
000234 (2020) Yongqi Deng [République populaire de Chine] ; Hui Luo [République populaire de Chine] ; Jun Shu [République populaire de Chine] ; Haiyang Shu [République populaire de Chine] ; Cheng Lu [République populaire de Chine] ; Ning Zhao [République populaire de Chine] ; Yun Geng [République populaire de Chine] ; Xiaojuan He [République populaire de Chine] ; Aiping Lu [République populaire de Chine]Pien Tze Huang alleviate the joint inflammation in collagen-induced arthritis mice
000240 (2020) James Kalmuk [États-Unis] ; Jon Puchalla [États-Unis] ; Gong Feng [États-Unis] ; Anshu Giri [États-Unis] ; John Kaczmar [États-Unis]Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge
000251 (2020) Simona Di Giambenedetto ; Arturo Ciccullo ; Alberto Borghetti ; Giovanni Gambassi [Italie] ; Francesco Landi [Italie] ; Elena Visconti ; Lorenzo Zileri Dal Verme ; Roberto Bernabei [Italie] ; Enrica Tamburrini ; Roberto Cauda ; Antonio Gasbarrini [Italie]Off-label Use of Tocilizumab in Patients with SARS-CoV-2 Infection.
000254 (2020) Yan Guo [République populaire de Chine] ; Hai Li [République populaire de Chine] ; Xueying Chen [République populaire de Chine] ; Huasheng Yang [République populaire de Chine] ; Hongyu Guan [République populaire de Chine] ; Xiaoying He [République populaire de Chine] ; Yuxin Chen [République populaire de Chine] ; Sunil Pokharel [République populaire de Chine] ; Haipeng Xiao [République populaire de Chine] ; Yanbing Li [République populaire de Chine]Novel Roles of Chloroquine and Hydroxychloroquine in Graves’ Orbitopathy Therapy by Targeting Orbital Fibroblasts
000258 (2020) Peter N. Taylor [Royaume-Uni] ; Lei Zhang [Royaume-Uni] ; Richard W J. Lee [Royaume-Uni] ; Ilaria Muller [Royaume-Uni] ; Daniel G. Ezra [Royaume-Uni] ; Colin M. Dayan [Royaume-Uni] ; George J. Kahaly [Allemagne] ; Marian Ludgate [Royaume-Uni]New insights into the pathogenesis and nonsurgical management of Graves orbitopathy.
000260 (2020) Ruksana HudaNew Approaches to Targeting B Cells for Myasthenia Gravis Therapy

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "therapy" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "therapy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    therapy
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021